Figure 6:
Genes showing significant change in expression (p=<0.05) on exposure to pelareorep in KRAS mutated patients at least in two out of three time points (48 hours, Day8 and Day 15) normalized to pre-pelareorep therapy.
*Genes with signficant change on at least 2/3 time points